Weekly round up from Life Sciences Industry.
Shanghai-based medical AI startup Synyi announced that it has raised RMB 250M ($36.3M) in Series C funding led by Chinese tech giant Tencent. Founded in 2016, Synyi started with Natural Language Processing (NLP) capabilities in the Chinese language and focused on hospitals? demand for scientific research data, combining AI & HIT to create their first smart analytics platform.
Date: July 15, 2019
Source: Telezkope
Sign up for DistilINFO e-Newsletters.
Biogen and Ginkgo Bioworks Partner to Redefine AAV-Based Vector Manufacturing
FDA clears first magnetic, noninvasive device treatment for OCD
BioVie Announces Amended Terms for Asset Acquisition from Privately Held NeurMedix
MercachemSyncom Closes the Acquisition of Admescope
Amwell Hits Market After Expanding Its IPO
Steris Expands Healthcare Consumables Offering with Acquisition of Key Surgical for Approximately $850 Million
Spinal Elements® Announces the Acquisition of Benvenue Medical Assets
Viewpoint Molecular Targeting Announces Transformational Merger